###begin article-title 0
Identification of a transcription factor IIIA-interacting protein
###end article-title 0
###begin p 1
To whom correspondence should be addressed. Tel: +1 405 271 2995; Fax: +1 405 271 5440; Email: jay-hanas@ouhsc.edu
###end p 1
###begin p 2
###xml 148 149 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 152 153 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 777 785 777 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 848 855 848 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1272 1279 1272 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 319 324 <span type="species:ncbi:4932">yeast</span>
###xml 427 430 <span type="species:ncbi:10116">rat</span>
###xml 535 540 <span type="species:ncbi:4932">yeast</span>
###xml 590 595 <span type="species:ncbi:4932">yeast</span>
###xml 609 612 <span type="species:ncbi:10116">rat</span>
###xml 666 671 <span type="species:ncbi:9606">human</span>
###xml 813 818 <span type="species:ncbi:9606">human</span>
###xml 966 969 <span type="species:ncbi:10116">rat</span>
###xml 982 985 <span type="species:ncbi:10116">rat</span>
###xml 1094 1097 <span type="species:ncbi:10116">rat</span>
###xml 1350 1355 <span type="species:ncbi:9606">human</span>
Transcription factor IIIA (TFIIIA) activates 5S ribosomal RNA gene transcription in eukaryotes. The protein from vertebrates has nine contiguous Cys2His2 zinc fingers which function in nucleic acid binding, and a C-terminal region involved in transcription activation. In order to identify protein partners for TFIIIA, yeast two-hybrid screens were performed using the C-terminal region of Xenopus TFIIIA as an attractor and a rat cDNA library as a source of potential partners. A cDNA clone was identified which produced a protein in yeast that interacted with Xenopus TFIIIA but not with yeast TFIIIA. This rat clone was sequenced and the primary structure of the human homolog (termed TFIIIA-intP for TFIIIA-interacting protein) was determined from expressed sequence tags. In vitro interaction of recombinant human TFIIIA-intP with recombinant Xenopus TFIIIA was demonstrated by immunoprecipitation of the complex using anti-TFIIIA-intP antibody. Interaction of rat TFIIIA with rat TFIIIA-intP was indicated by co-chromatography of the two proteins on DEAE-5PW following fractionation of a rat liver extract on cation, anion and gel filtration resins. In a HeLa cell nuclear extract, recombinant TFIIIA-intP was able to stimulate TFIIIA-dependent transcription of the Xenopus 5S ribosomal RNA gene but not TFIIIA-independent transcription of the human adenovirus VA RNA gene.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c3">3</xref>
###xml 269 276 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c4">4</xref>
###xml 804 805 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c5">5</xref>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c11">11</xref>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c12">12</xref>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c13">13</xref>
###xml 1116 1124 1116 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1166 1167 1166 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c8">8</xref>
###xml 1168 1169 1168 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c9">9</xref>
###xml 1176 1183 1176 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1244 1252 1244 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1254 1256 1254 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c14">14</xref>
###xml 995 1000 <span type="species:ncbi:4932">yeast</span>
###xml 1063 1068 <span type="species:ncbi:4932">yeast</span>
###xml 1188 1193 <span type="species:ncbi:9606">human</span>
Transcription of 5S ribosomal RNA genes by RNA polymerase III requires three transcription factors, TFIIIA, TFIIIB and TFIIIC, whereas transcription of tRNA and adenovirus VA RNA genes requires only TFIIIB and TFIIIC (1-3). TFIIIB and TFIIIC, but not TFIIIA, associate in vivo with polymerase III forming a 'holoenzyme' (4). These observations demonstrate the TFIIIIA dependence of polymerase III transcription of 5S genes and indicate that the transcription mechanism is distinct from that of tRNA and adenovirus VA genes. Understanding the biochemical details of vertebrate 5S RNA gene transcription will require elucidation of the structure and function of the protein factors involved in this mechanism. Factor IIIA is a single protein whereas factors IIIB and IIIC contain multiple protein species (5-11). Little information is available on the structure of RNA polymerase III initiation complexes in vertebrates whereas more information is available on the structure of these complexes in yeast (12,13). In the case of TFIIIA and 5S gene transcription, the yeast and vertebrate systems are not interchangeable in vitro and a number of proteins are not shared (8,9). The Xenopus and human 5S gene transcription systems are interchangeable in vitro (14).
###end p 4
###begin p 5
###xml 96 110 96 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 234 235 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c15">15</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c18">18</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c19">19</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c24">24</xref>
###xml 581 588 581 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c22">22</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c23">23</xref>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c25">25</xref>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c28">28</xref>
###xml 1038 1045 1038 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1163 1165 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c29">29</xref>
###xml 1166 1168 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c30">30</xref>
###xml 1249 1256 1237 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1317 1319 1305 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c31">31</xref>
###xml 1320 1322 1308 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c32">32</xref>
###xml 96 110 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 907 912 <span type="species:ncbi:9606">human</span>
###xml 992 997 <span type="species:ncbi:4932">yeast</span>
###xml 1210 1215 <span type="species:ncbi:4932">yeast</span>
###xml 1260 1265 <span type="species:ncbi:9606">human</span>
Considerable structural and functional information is available concerning TFIIIA isolated from Xenopus laevis oocytes. This 38 kDa protein was the first gene regulatory factor discovered to contain zinc and possess repetitive Cys2His2 zinc binding domains referred to as zinc fingers (15-18). These fingers bind the 50 bp internal control region (ICR) of the 5S gene in three groups of three: the N-terminal finger group contacts the 3' ICR C-box, the middle group contacts the ICR intermediate element and the C-terminal finger group contacts the A-box 5' ICR sequences (19-24). Xenopus TFIIIA zinc fingers are also involved in binding the 5S ribosomal RNA transcript (22,23). The binding orientation of the TFIIIA zinc fingers on the ICR positions the C-terminal region of the protein pointing upstream toward the start site of 5S RNA transcription. This C-terminal region is conserved in amphibians and human TFIIIA and is essential for transcription activation (25-28). The structure of yeast TFIIIA differs significantly to that of Xenopus and all other known vertebrate TFIIIAs, sharing only approximately20% amino acid sequence identity with frog TFIIIA (29,30). The transcription activation region of yeast TFIIIA does not resemble that of Xenopus or human TFIIIA and is located between fingers VIII and IX (31,32).
###end p 5
###begin p 6
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c33">33</xref>
###xml 517 524 517 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 658 666 658 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 763 771 763 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 202 207 <span type="species:ncbi:4932">yeast</span>
###xml 417 422 <span type="species:ncbi:4932">yeast</span>
The identification and characterization of proteins that interact with the C-terminal portion of TFIIIA will aid in the elucidation of the 5S gene transcription activation mechanism in vertebrates. The yeast two-hybrid screen is a useful experimental tool for identifying cDNA clones from a tissue library that code for proteins that can physically interact with a protein of interest (33). In the present study, the yeast two-hybrid system was used to identify proteins which interact with the C-terminal portion of Xenopus TFIIIA. A 70.6 kDa protein previously not associated with RNA polymerase III transcription was identified that interacts with TFIIIA in vitro and in cell extracts. This protein stimulates TFIIIA-dependent transcription of the 5S RNA gene in vitro but not TFIIIA-independent transcription of the adenovirus VA gene.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
###xml 40 45 <span type="species:ncbi:4932">yeast</span>
Construction of pAS1-TFIIIA fusions and yeast transformations
###end title 8
###begin p 9
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c34">34</xref>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 314 322 314 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X.laevis</italic>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c15">15</xref>
###xml 422 425 422 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 432 435 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 691 715 691 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c35">35</xref>
###xml 1000 1001 997 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1377 1378 1350 1351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 39 44 <span type="species:ncbi:4932">yeast</span>
###xml 314 322 <span type="species:ncbi:8355">X.laevis</span>
###xml 547 552 <span type="species:ncbi:4932">yeast</span>
###xml 691 715 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 809 814 <span type="species:ncbi:4932">Yeast</span>
###xml 902 907 <span type="species:ncbi:4932">Yeast</span>
Yeast plasmid pAS1 (34) containing the yeast GAL4 DNA binding domain was kindly provided by Steven Elledge. The cDNA sequence coding for zinc fingers VII-IX (starting at amino acid 189, QDLAV) and the C-terminal region of Xenopus TFIIIA (ending at KLTIQ, amino acid 344) was amplified using as template the 1.5-kb X.laevis TFIIIA cDNA clone (15) kindly provided by Robert Roeder. Upstream and downstream primers contained BamHI and SalI sites respectively to allow in-frame cloning into pAS1. A similar strategy was used in the sub-cloning of the yeast TFIIIA insert containing zinc fingers V-IX (starting at amino acid 187, DPEVE) and the C-terminal tail (ending at SAGDK, amino acid 428). Saccharomyces cerevisiae genomic DNA obtained from Promega Life Sciences (Madison, WI) was used for the PCR template. Yeast transformation was performed by modification of a previously described procedure (35). Yeast strain Y190 (containing beta-galactosidase and His reporter genes) was grown to about 1 x 107 cells/ml in YTDA media. Cells were pelleted and resuspended in 1 ml of 100 mM lithium acetate and 10 mM Tris-HCl, pH 7.6, 1 mM EDTA. An aliquot of 200 microl of this cell suspension was mixed with 2-4 microg plasmid DNA, 200 microg carrier DNA, 1.2 ml 40% PEG and shaken at 30degreesC for 30 min. Cells were placed at 42degreesC for 15 min, pelleted, resuspended in sterile H2O and plated overnight.
###end p 9
###begin title 10
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast lysate preparation and western blotting
###end title 10
###begin p 11
###xml 28 32 28 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">frog</sub>
###xml 42 47 42 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">yeast</sub>
###xml 943 954 <span type="species:ncbi:3704">horseradish</span>
Cells containing pAS1-TFIIIAfrog or TFIIIAyeast were pelleted from 10 ml cultures, resuspended in 200 microl of 16.6% pre-chilled trichloroacetic acid and vortexed repeatedly with siliconized glass beads. The suspension was centrifuged to pellet the protein, washed with 100% ethanol and resuspended in 100 microl SDS-PAGE loading buffer; the pH was adjusted to 6-7 with 1 M Tris-HCl, pH 10. Samples were electrophoresed through a 12% polyacrylamide SDS gel and transferred to a 0.45 microm nitrocellulose filter using an IDEA Scientific trans-blot cell. The filter was blocked with 3% non-fat dry milk in 10 mM Tris-HCl, pH 7.4, 140 mM NaCl and incubated in the same solution overnight with the appropriate antibody. The blot was rinsed and incubated with secondary antibody for 1 h. For alkaline phosphatase-conjugated secondary antibody, the blot was developed with NBT (1 microg/ml) and BCIP (0.5 microg/ml) in 20 mM Tris-HCl, pH 9.5; for horseradish peroxidase antibody, development was performed using the Renaissance Chemiluminescence kit from New England Nuclear (Boston, MA).
###end p 11
###begin title 12
###xml 52 57 <span type="species:ncbi:4932">yeast</span>
Library screening, beta-galactosidase filter assay, yeast plasmid isolation and characterization
###end title 12
###begin p 13
###xml 46 50 46 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">frog</sub>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c36">36</xref>
###xml 415 416 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 451 452 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 457 458 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 463 464 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 747 748 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 772 773 763 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 775 776 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 788 789 779 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 792 793 783 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 969 970 947 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 974 975 952 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 113 116 <span type="species:ncbi:10116">rat</span>
###xml 1070 1075 <span type="species:ncbi:4932">yeast</span>
###xml 1276 1281 <span type="species:ncbi:4932">yeast</span>
###xml 1346 1351 <span type="species:ncbi:4932">yeast</span>
Yeast strain Y190 transformed with pAS1-TFIIIAfrog was grown in SC media minus tryptophan and transformed with a rat brain cDNA pACT library (36) kindly provided by Ian Macara. The transformation mix was distributed on SC plates lacking tryptophan, leucine and histidine but including 25 mM 3-aminotriazole (3-AT, Sigma Chemical Co., St Louis, MO; A8056) and incubated for 4-5 days at 30degreesC. A total of 12 x 106 transformants were assayed for Trp+, Leu+, His+ growth in four independent screens. To assay for beta-galactosidase activity, Ahlstrom grade 95 paper filters were exposed to the plate surfaces followed by freezing in liquid nitrogen and then thawing at room temperature. The filter was placed in a Petri dish and 1 ml of 1 mM MgSO4, 10 mM KCl, 5.5 g/l NaH2PO4, 8.5 g/l Na2HPO4, 40 microl of X-gal (20 mg/ml) was added followed by incubation at 37degreesC overnight. Positive colonies were reassayed for beta-galactosidase activity and then grown in Leu- Trp+ media to remove the pAS1-TFIIIA plasmids. The remaining pACT plasmids were purified from 5 ml yeast cultures by vortexing cell pellets with glass beads in 100 mM Tris-HCl, pH 8.0, 50 mM EDTA, 1% SDS followed by phenol/chloroform extraction and ethanol precipitation. Plasmid DNA was transformed into yeast cells containing pAS1-Gal4 fusions to either SNF1, lamin or the yeast TFIIIA and assayed for beta-galactosidase activity.
###end p 13
###begin title 14
Sequence analysis, expression and purification of recombinant proteins
###end title 14
###begin p 15
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c37">37</xref>
###xml 690 693 690 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bbs</italic>
###xml 869 872 869 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 878 881 878 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1486 1493 1480 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1688 1689 1678 1679 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1691 1692 1681 1682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 2009 2011 1993 1995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c38">38</xref>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 89 94 <span type="species:ncbi:4932">yeast</span>
###xml 351 356 <span type="species:ncbi:9606">human</span>
###xml 400 406 <span type="species:ncbi:9606">infant</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
Rat pACT which tested positive in the two-hybrid screen with Xenopus TFIIIA but not with yeast TFIIIA was digested with XhoI; the cDNA insert was cloned into pTrcHis (Invitrogen, Carlsbad, CA) for expression and into pBluescript (Stratagene, La Jolla, CA) for sequencing (37). An open reading frame (ORF) was observed that displayed 85% identity to a human expressed sequence tag (EST) clone from an infant brain library (clone ID 38702; 5' and 3' sequence accession numbers, R36308 and R49240). Another EST clone (ID 757436; 5' and 3' sequence accession numbers, AA442279 and AA437216) from a human testis cDNA library contained an additional 1000 nt. These two EST clones shared a common BbsI restriction site which was used to splice them together. This procedure yielded a 3-kb cDNA fragment which was cloned into the pET vector 28a(+) (Novagen, Madison, WI) using SacI and NotI sites. The protein coded by this construct, termed TFIIIA-intP for TFIIIA-interacting protein, was expressed in BL21(DE3) cells by induction with IPTG. Cells were pelleted, suspended in 40 mM Tris-HCl, pH 7.4, 6 M guanidine-HCl, 0.5 M NaCl, 10% glycerol, 20 mM imidazole (pH 8.0), broken in a French press and centrifuged at 30 000 r.p.m. in a Beckman Ti45 rotor. The supernatant was loaded on a ProBond Resin column (Invitrogen) and eluted with the same buffer containing 0.3 M imidazole. The eluate was dialyzed against this buffer minus the guanidine/imidazole and stored at -80degreesC. Recombinant Xenopus TFIIIA was expressed from plasmid pT7-TFIIIA in a similar fashion and cells were broken in a French press in 40 mM Tris-HCl, pH 7.4, 100 mM KCl, 5 M urea, 1 mM dithiothreitol (DTT), 50 microM Zn2SO4 and 10% glycerol. The extract was centrifuged and loaded on a SP Sepharose column equilibrated in the breaking buffer. TFIIIA, eluting in 0.3 M KCl breaking buffer, was dialyzed against breaking buffer minus the urea, and stored at -80degreesC. Recombinant protein amounts were determined by the dye-binding method (38).
###end p 15
###begin title 16
Affinity purification of anti-TFIIIA intP antibody and immunoprecipitation
###end title 16
###begin p 17
###xml 795 802 795 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1310 1317 1288 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 163 169 <span type="species:ncbi:9986">rabbit</span>
###xml 306 309 <span type="species:ncbi:10116">rat</span>
###xml 484 490 <span type="species:ncbi:9986">rabbit</span>
###xml 708 713 <span type="species:ncbi:9606">human</span>
###xml 1146 1151 <span type="species:ncbi:9606">human</span>
Rat cDNA for TFIIIA-intP cloned in pTrcHis was expressed and purified as described above. Purified protein was electrophoresed on a 12% polyacrylamide SDS gel and rabbit polyclonal antiserum was developed against the TFIIIA-intP PAGE band at Cocalico Biologicals (Reamstown, PA). Thirty-four milligrams of rat TFIIIA-intP was reacted with Affi-Gel 10 resin according to the manufacturer's directions (Bio-Rad, Hercules, CA). Unconjugated resin was blocked with 0.1 M ethanolamine and rabbit antiserum was applied to the resin and washed repeatedly. The bound antibody was eluted with 200 mM glycine (pH 2.0), 100 mM NaCl and neutralized with 1.0 M Tris-HCl, pH 10. This antibody reacted with the recombinant human TFIIIA-intP at a 1:5000 dilution in western blotting. Immunoprecipitation of the Xenopus TFIIIA-TFIIIA-intP complex was performed using the Immuno Catcher kit (CytoSignal, Irvine, CA). Fifty microliters of the purified TFIIIA intP antibody (3 microg protein) were incubated for 30 min at 23degreesC with 30 microl bed volume of protein A/G binding resin; unbound antibody was washed from the resin and then 10 microg of recombinant human TFIIIA-intP was bound for 1.5 h. The resin was washed twice with 20 mM HEPES, pH 7.9, 0.1 M KCl, 10% glycerol followed by addition of 6 microg of recombinant Xenopus TFIIIA; the reaction was incubated in the same buffer for 2 h at 23degreesC. The resin was washed six times with 20 mM HEPES, pH 7.9, 0.3 M KCl, 10% glycerol; the bound protein was eluted with SDS-PAGE sample buffer and electrophoresed through a 12% polyacrylamide SDS gel.
###end p 17
###begin title 18
###xml 33 36 <span type="species:ncbi:10116">rat</span>
###xml 41 46 <span type="species:ncbi:9606">human</span>
Chromatographic fractionation of rat and human cell extracts
###end title 18
###begin p 19
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c39">39</xref>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 905 906 905 906 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 907 908 907 908 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 910 911 910 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1060 1061 1060 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 2 5 <span type="species:ncbi:10116">rat</span>
A rat liver cytosol was prepared and fractionated by (NH4)2SO4 precipitation as described (39). The 0-38% fraction containing TFIIIA-intP (assayed in this and subsequent fractions by western blot) was resuspended in 20 mM HEPES-NaOH, pH 7.9, 0.5 mM EDTA, 1 mM DTT, 10% glycerol (buffer A), 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml of antipain and leupeptin. Following centrifugation at 28 000 g, the supernatant was fractionated on phosphocellulose (P11; Whatman, Clifton, NJ) pre-equilibrated in buffer A containing 100 mM KCl and 0.5 mM PMSF. The flow-through containing TFIIIA-intP was fractionated on Toyopearl DEAE-650M (TosoHaas, Montgomeryville, PA) pre-equilibrated in buffer C (40 mM Tris-HCl, pH 7.9, 0.5 mM EDTA, 1 mM DTT, 10% v/v glycerol), 80 mM KCl. The 1000 mM KCl fraction containing TFIIIA-intP was dialyzed against buffer A containing 100 mM KCl and then concentrated by (NH4)2SO4 precipitation. The pellet was resuspended in 10 ml buffer A and dialyzed against buffer A containing 100 mM KCl. Following centrifugation at 12 000 g, the supernatant was applied to an Ultrogel AcA34 gel filtration column pre-equilibrated with buffer A containing 400 mM KCl. Column fractions containing TFIIIA-intP were diluted with an equal volume of buffer C containing no salt and applied to a TSK DEAE-5PW column pre-equilibrated in buffer C containing 200 mM KCl; column contents were eluted with a 10 column volume gradient to 1000 mM KCl. For transcription assays, HeLa nuclear extract (Promega) was loaded on a 1 ml P11 column pre-equilibrated in buffer A containing 100 mM KCl. The contents on the column were washed with buffer A containing 100 mM KCl and then eluted with buffer A containing 800 mM KCl; aliquots were frozen at -80degreesC.
###end p 19
###begin title 20
Transcription assays
###end title 20
###begin p 21
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c40">40</xref>
###xml 364 365 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 469 471 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 598 599 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f7">7</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 952 957 <span type="species:ncbi:4932">yeast</span>
In vitro transcription of the Xenopus 5S ribosomal gene and the human adenovirus VA RNA gene (kindly provided by Guang Jer Wu, 40) was performed using the phosphocellulose 0.8 M KCl fraction of the human nuclear extract as a source of RNA polymerase III and associated factors. Transcription assays (25 microl) contained 10 mM HEPES, pH 7.9, 50 mM KCl, 1.5 mM MgCl2, 0.25 mM DTT, 0.1 mM EDTA, 10% glycerol, 400 microM (GTP, ATP, UTP), 1.6 microM CTP, 10 microCi [alpha-32P]CTP, 3 microg phosphocellulose fraction; plasmid and recombinant protein additions are described in the legend to the Figure 7. Plasmids and recombinant proteins were incubated in the transcription buffer with the phosphocellulose fraction for 30 min at 30degreesC in the absence of nucleotides and then for 1 h in the presence of nucleotides. The reactions were quenched with 100 microl SDS buffer (0.5% SDS, 0.3 M Tris-HCl, pH 7.4, 0.3 M sodium acetate, 2 mM EDTA, 3 microg/ml yeast tRNA), phenol-chloroform extracted, and ethanol precipitated. Samples were resuspended in 10 mM EDTA, pH 8.0, 98% deionized formamide, 0.04% xylene cyanol/bromophenol blue and heated at 65degreesC. Samples were electrophoresed through a 7% polyacrylamide gel containing 7 M urea and 89 mM Tris, 110 mM boric acid, 1 mM EDTA, pH 8.0. Gels were subjected to autoradiography overnight using Kodak XAR5 film.
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23
Two-hybrid screen for TFIIIA-interacting proteins
###end title 23
###begin p 24
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f1">1</xref>
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f1">1</xref>
###xml 515 522 515 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f1">1</xref>
###xml 704 711 704 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 877 878 877 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f2">2</xref>
###xml 902 909 902 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
###xml 160 165 <span type="species:ncbi:4932">yeast</span>
###xml 677 682 <span type="species:ncbi:4932">yeast</span>
###xml 694 699 <span type="species:ncbi:4932">yeast</span>
###xml 969 974 <span type="species:ncbi:4932">yeast</span>
Figure 1 exhibits the polypeptide regions of yeast (A) and Xenopus (B) TFIIIA used to construct the GAL4 DNA binding domain fusions. Rather than clone just the yeast transcription activation region located between fingers XIII and XI into the GAL4 construct, the surrounding fingers beginning at finger VI (Fig. 1A, arrow) and extending to the C-terminus were used for the construction. This was done to possibly help maintain the conformational stability of the activation domain. The same approach was taken with Xenopus TFIIIA where the C-terminal region was cloned along with the C-terminal fingers VII, VIII and IX (Fig. 1B, arrow) into the GAL4 fusion. When expressed in yeast cells, the yeast and Xenopus GAL4 constructs yielded fusion proteins of the appropriate size when analyzed by western blotting using either an antibody against the GAL4 DNA binding domain (Fig. 2, lanes 1-4) or against Xenopus TFIIIA (lanes 7 and 8). The larger molecular weight of the yeast TFIIIA fusion (approximately10K, lanes 3 and 4) reflects the additional amino acids present.
###end p 24
###begin p 25
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 268 275 268 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 359 367 359 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c28">28</xref>
###xml 459 466 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 813 814 813 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f3">3</xref>
###xml 979 986 976 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1008 1009 1005 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f3">3</xref>
###xml 1120 1121 1117 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f3">3</xref>
###xml 1142 1143 1139 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f3">3</xref>
###xml 1161 1162 1158 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f3">3</xref>
###xml 1307 1314 1304 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1490 1497 1487 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 29 32 <span type="species:ncbi:10116">rat</span>
###xml 355 358 <span type="species:ncbi:10116">rat</span>
###xml 405 408 <span type="species:ncbi:10116">rat</span>
###xml 438 443 <span type="species:ncbi:4932">yeast</span>
###xml 662 667 <span type="species:ncbi:4932">yeast</span>
###xml 744 749 <span type="species:ncbi:4932">yeast</span>
###xml 1101 1106 <span type="species:ncbi:4932">Yeast</span>
###xml 1125 1130 <span type="species:ncbi:4932">yeast</span>
###xml 1354 1359 <span type="species:ncbi:4932">yeast</span>
For the two-hybrid screen, a rat pACT cDNA expression library was used as a source for potential Xenopus TFIIIA-interacting proteins. This was done because of the availability of this high-complexity library for our studies and because we previously demonstrated that Xenopus TFIIIA promoted transcription of the Xenopus 5S RNA gene to a high degree in a rat in vitro transcription system (28). When this rat library was transformed into yeast expressing the Xenopus TFIIIA-GAL4 construct, a number of positive clones were observed among four independent screens. Four of the clones that were consistently positive and that were negative when retransformed into yeast cells lacking the TFIIIA-GAL4 fusion were additionally screened against the yeast TFIIIA construct as well as the SNF1 or lamin constructs (Fig. 3). Of these four, two were strongly positive for beta-galactosidase activity (clones 3 and 4) and two were weakly positive (clones 1 and 2) when assayed against the Xenopus-GAL4 construct (Fig. 3A). Of the two strongly positive ones, clone 4 was also strongly positive when assayed with Yeast TFIIIA (Fig. 3B), yeast SNF1 (Fig. 3C) or lamin (Fig. 3D). The protein coded by this clone may be interacting with the GAL4 DNA binding domain. Significantly, the other strongly interacting clone for Xenopus TFIIIA (clone 3) did not interact with yeast TFIIIA, SNF1 or lamin. These results suggest that this clone may code for a protein that interacts with the C-terminal portion of Xenopus TFIIIA. This putative protein was termed TFIIIA-intP for 'TFIIIA-interacting protein'.
###end p 25
###begin title 26
Sequence analysis of the TFIIIA-intP two-hybrid clone
###end title 26
###begin p 27
###xml 27 28 27 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f3">3</xref>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f4">4</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f4">4</xref>
###xml 788 789 788 789 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1057 1079 1057 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 107 110 <span type="species:ncbi:10116">rat</span>
###xml 220 223 <span type="species:ncbi:10116">rat</span>
###xml 282 287 <span type="species:ncbi:9606">human</span>
###xml 491 496 <span type="species:ncbi:9606">human</span>
###xml 623 628 <span type="species:ncbi:9606">human</span>
###xml 737 740 <span type="species:ncbi:10116">rat</span>
###xml 946 949 <span type="species:ncbi:9823">pig</span>
###xml 1005 1010 <span type="species:ncbi:9606">human</span>
###xml 1047 1052 <span type="species:ncbi:4932">yeast</span>
###xml 1057 1079 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Clone number 3 from Figure 3 was sequenced and found to contain an ORF coding for 343 amino acids (Fig. 4, rat TFIIIA-intP). No N-terminal methionine was observed so this sequence is likely from an incomplete cDNA. This rat sequence was found to share 85% identity with a number of human ESTs (see Materials and Methods), including 100% identity over a leucine-rich, 36 amino acid stretch. Using these ESTs along with confirmatory sequencing, a complete amino acid sequence for the apparent human homolog for this protein was assembled (Fig. 4), yielding a protein of 617 amino acids with a molecular weight of 70 600. The human sequence has numerous leucine zipper and other leucine-rich regions that are present and conserved with the rat sequence. The sequence contains a potential Cys2HisCys zinc finger at residues 553-582. The protein is rich in glutamate (14.7%) and has an acidic pI. EST database searches in other organisms identified a pig sequence (AU059594) with 92% sequence identity to this human sequence. Searches of the completed yeast and Caenorhabditis elegans genomes revealed no apparent homologies to the TFIIIA-intP sequence.
###end p 27
###begin title 28
Interaction of TFIIIA-intP and TFIIIA recombinant proteins
###end title 28
###begin p 29
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 164 165 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f3">3</xref>
###xml 215 223 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 252 260 249 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 281 288 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 670 677 667 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 700 701 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f5">5</xref>
###xml 893 900 866 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1110 1117 1083 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1148 1150 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c41">41</xref>
###xml 1151 1153 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c42">42</xref>
###xml 1685 1692 1658 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 72 75 <span type="species:ncbi:10116">rat</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
###xml 1708 1713 <span type="species:ncbi:9606">human</span>
Although an in vivo interaction between Xenopus TFIIIA and the proposed rat TFIIIA-intP is indicated by the positive beta-galactosidase assay for clone 3 in Figure 3, it was necessary to demonstrate the interaction in vitro. In order to demonstrate an in vitro interaction between Xenopus TFIIIA and the human homolog, recombinant forms of both proteins were expressed, purified, and incubated together to allow potential interactions to occur. The binding reaction was subjected to immunoprecipitation using anti-TFIIIA-intP antibody followed by IgG selection with protein A/G resin. After selection, complexes were subjected to SDS-PAGE and western blotting with anti-Xenopus TFIIIA antibody (Fig. 5). Electrophoresed in lane 1 is the recombinant TFIIIA protein; two bands of equal intensity are observed, one at approximately40 and the other at approximately30K. The 40K band is the intact Xenopus TFIIIA protein containing the nine zinc fingers (30K) and the non-finger C-terminal tail (10K). The 30K band migrating below the 40K band is possibly the nine zinc-finger region since the C-terminal region of Xenopus TFIIIA is protease sensitive (41,42) and protease inhibitors were not used in the preparation of the recombinant protein. Lanes 2 and 3 exhibit the protein A/G selected complexes from TFIIIA binding reactions containing or lacking the TFIIIA-intP protein respectively. In the absence of the TFIIIA-intP (lane 3), very little recombinant TFIIIA protein is precipitated, demonstrating that complex selection is dependent on TFIIIA-intP. Markedly more TFIIIA (40K band) is selected in the presence of TFIIIA-intP (lane 2) demonstrating that a complex was formed between Xenopus TFIIIA and the human TFIIIA-intP. The affinity purified anti-TFIIIA-intP antibody does not immunoprecipitate TFIIIA in the absence of TFIIIA-intP (not shown). It is noted that very little of the 30K band was found in the TFIIIA-TFIIIA-intP complex (lane 2); this could be explained by lack of interaction between TFIIIA-intP and any TFIIIA lacking the C-terminal region.
###end p 29
###begin title 30
###xml 45 48 <span type="species:ncbi:10116">rat</span>
Interaction of TFIIIA and TFIIIA-intP from a rat liver extract
###end title 30
###begin p 31
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f6">6</xref>
###xml 1009 1010 1009 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f6">6</xref>
###xml 1308 1309 1308 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f6">6</xref>
###xml 1460 1467 1460 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 307 310 <span type="species:ncbi:10116">rat</span>
###xml 327 330 <span type="species:ncbi:10116">rat</span>
###xml 809 812 <span type="species:ncbi:10116">rat</span>
###xml 878 881 <span type="species:ncbi:10116">Rat</span>
###xml 1093 1096 <span type="species:ncbi:10116">rat</span>
###xml 1193 1196 <span type="species:ncbi:10116">rat</span>
###xml 1415 1418 <span type="species:ncbi:10116">rat</span>
###xml 1528 1531 <span type="species:ncbi:10116">rat</span>
###xml 1543 1546 <span type="species:ncbi:10116">rat</span>
###xml 1743 1746 <span type="species:ncbi:10116">rat</span>
An experiment that would lend physiological significance to the interaction of TFIIIA and TFIIIA-intP observed with recombinant proteins would be to identify an interaction between the native proteins from a cell extract. One way to identify such an interaction would be to demonstrate co-chromatography of rat TFIIIA-intP and rat TFIIIA after several distinct chromatographic separations of the original cell extract. These separations should take advantage of disparate physical characteristics of the proteins-e.g., TFIIIA-intP is a 70K acidic protein and TFIIIA is a 38K basic protein. Such co-chromatography would be indicative of the presence of the complex in the cell extract and its maintenance during column fractionation. The separation protocol used in this experiment is depicted in Figure 6A. A rat liver cytosol was prepared and fractionated on phosphocellulose. Rat TFIIIA-intP was found in the flow-through (because of its acidic nature) when assayed with the anti-TFIIIA-intP antibody (Fig. 6B, lane 1). This flow-through was then fractionated on a DEAE 650 column where the rat TFIIIA-intP fraction eluted at 1 M KCl. This fraction was then subjected to gel filtration; the rat TFIIIA-intP peak was identified and fractionated on DEAE-5PW whose western blot profile is exhibited in Figure 6C (top panel). Significantly, this chromatographic profile is the same as the chromatographic profile for rat TFIIIA on this column as detected by the Xenopus TFIIIA antibody (bottom panel). These results indicate that rat TFIIIA and rat TFIIIA-intP proteins co-fractionated as a complex on this column since TFIIIA alone does not bind to DEAE (not shown). The result is also consistent with the complex being present in the original rat cell extract and with its survival through phosphocellulose, DEAE (1 M KCl) and gel filtration chromatography.
###end p 31
###begin title 32
Stimulation of 5S gene transcription by recombinant TFIIIA-intP
###end title 32
###begin p 33
###xml 226 234 226 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f7">7</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f7">7</xref>
###xml 577 584 577 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c14">14</xref>
###xml 1583 1584 1583 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f7">7</xref>
###xml 833 838 <span type="species:ncbi:9606">human</span>
###xml 885 890 <span type="species:ncbi:9606">human</span>
###xml 1993 1998 <span type="species:ncbi:9606">human</span>
Evidence is presented in the previous experiments indicating that a physical interaction can take place between TFIIIA and TFIIIA-intP. In order to demonstrate whether there is any functional significance to this interaction, in vitro transcription assays (using the 0.8 M KCl phosphocellulose fraction from a HeLa cell nuclear extract) were performed to examine for effects of TFIIIA-intP on 5S RNA gene or adenovirus VA RNA gene transcription by RNA polymerase III (Fig. 7). Lanes 1 and 2 in Figure 7A are 5S gene-containing transcription reactions minus or plus recombinant Xenopus TFIIIA. A 5S RNA signal is observed in the plus recombinant TFIIIA lane and little if any signal is observed in the minus lane. Longer autoradiogram exposures do reveal a weaker 5S RNA band in the minus TFIIIA lane (not shown) indicating that some human TFIIIA is present in this 0.8 M KCl fraction; human TFIIIA was previously observed in this KCl phosphocellulose fraction by others (14). Importantly, addition of the TFIIIA-intP to the TFIIIA-dependent reaction (lane 2) markedly stimulated 5S RNA gene transcription (lane 3). This stimulation by TFIIIA-intP occurs in the absence of exogenously added TFIIIA as is exhibited in lanes 4-6. Also exhibited in these lanes is the diminution of the 5S RNA signal upon increasing amounts of the TFIIIA-intP. Such diminution could be caused by a TFIIIA-intP squelching phenomenon with the limiting amounts of endogenous TFIIIA present in the 0.8 M KCl fraction. Any potential effect of TFIIIA-intP on adenovirus VA transcription is exhibited in Figure 7B. Lanes 1 and 2 exhibit VA RNA transcription in this phosphocellulose column fraction in the absence and presence of the VA RNA gene; lanes 3 and 4 exhibit the transcription product in the presence of the VA gene and recombinant TFIIIA. The lack of signal in the no. 4 TFIIIA lane is due to loss of the ethanol precipitate. Lanes 5 and 6 exhibit the transcription products in the presence of the recombinant human TFIIIA-intP and lanes 7 and 8 exhibit the products in the presence of both recombinant TFIIIA and TFIIIA-intP. Little overall change in signal is observed in these lanes indicating that the TFIIIA-intP does not stimulate VA transcription.
###end p 33
###begin title 34
DISCUSSION
###end title 34
###begin p 35
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 310 317 310 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 516 523 516 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 771 772 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f4">4</xref>
###xml 889 897 889 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 915 922 915 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 936 937 936 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f5">5</xref>
###xml 240 245 <span type="species:ncbi:4932">yeast</span>
###xml 347 350 <span type="species:ncbi:10116">rat</span>
###xml 403 406 <span type="species:ncbi:10116">rat</span>
###xml 482 487 <span type="species:ncbi:4932">yeast</span>
###xml 593 598 <span type="species:ncbi:4932">yeast</span>
###xml 665 670 <span type="species:ncbi:9606">human</span>
###xml 688 691 <span type="species:ncbi:10116">rat</span>
###xml 827 832 <span type="species:ncbi:9606">human</span>
###xml 940 943 <span type="species:ncbi:10116">Rat</span>
###xml 955 958 <span type="species:ncbi:10116">rat</span>
###xml 1056 1059 <span type="species:ncbi:10116">rat</span>
Although a great deal of structural and nucleic acid binding data are available on Xenopus TFIIIA, little is known about how it activates 5S gene transcription and even less is known about proteins with which it interacts. In this study, a yeast two-hybrid screen was performed using the C-terminal portion of Xenopus TFIIIA as an attractor and a rat cDNA library as a source of potential partners. One rat cDNA clone was chosen for further study because its protein product in the yeast assay did interact with the Xenopus TFIIIA attractor but did not interact with the C-terminal portion of yeast TFIIIA or other non-TFIIIA proteins. The complete sequence of the human homolog for this rat protein was assembled from ESTs and found to code for a 70.6 kDa protein (Fig. 4). As assayed by immunoprecipitation, this recombinant human protein (termed TFIIIA-intP) was able to form a complex in vitro with recombinant Xenopus TFIIIA (Fig. 5). Rat TFIIIA and rat TFIIIA-intP co-chromatographed on DEAE-5PW after three distinct chromatographic separations of a rat cell extract. This observation is consistent with these two proteins being present in a complex on DEAE-5PW as well as in the original cell extract.
###end p 35
###begin p 36
###xml 470 471 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 558 559 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 562 563 562 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f4">4</xref>
###xml 999 1000 999 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f6">6</xref>
###xml 120 125 <span type="species:ncbi:9606">human</span>
###xml 616 619 <span type="species:ncbi:10116">rat</span>
With respect to possible structure(s) in TFIIIA-intP that may interact with the C-terminal portion of TFIIIA, the 70.6K human protein has several motif-rich regions of potential use for protein-protein interactions. The N-terminal quarter of the protein has potential leucine zipper regions and acidic amino acid-rich regions. The large middle portion of the protein also has several leucine-rich zipper regions. The C-terminal portion of TFIIIA-intP has a potential Cys2HisCys zinc finger, a variant where a cysteine replaces the second histidine in the Cys2His2 zinc coordination sphere (43). Because the original rat clone identified in the two-hybrid screen lacked both these N- and C-terminal portions (Fig. 4), the TFIIIA-interacting region is likely within the central leucine-rich central domain. A hydrophobic nature for the TFIIIA-TFIIIA-intP interaction is suggested by the observation that the complex of the two proteins (as evidenced by co-chromatography) is stable at high salt (Fig. 6).
###end p 36
###begin p 37
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f7">7</xref>
###xml 796 804 796 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 847 848 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd316f7">7</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
Recombinant human TFIIIA-intP stimulated TFIIIA-dependent 5S gene transcription in vitro but not TFIIIA-independent human adenovirus VA gene transcription (Fig. 7), a result consistent with TFIIIA specificity in the TFIIIA-intP reaction. What possible functions could TFIIIA-intP have in 5S gene transcription stimulation? Although the protein contains a potential zinc finger in its C-terminal region, we were not able to demonstrate DNA binding by this protein to the 5S gene or non-specific plasmid DNA (not shown). The potential zinc finger in its C-terminal region may have a role in 5S RNA binding like some of the TFIIIA fingers and we have yet to explore that possibility. If its does bind 5S RNA, it does not appear to do this in a protective manner as increasing amounts of the protein in vitro reduce the amount of 5S RNA product (Fig. 7). This could be due to squelching of a limiting amount of endogenous TFIIIA in the fractionated nuclear extract.
###end p 37
###begin p 38
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd316c44">44</xref>
###xml 592 597 <span type="species:ncbi:4932">yeast</span>
###xml 938 943 <span type="species:ncbi:9606">human</span>
TFIIIA-intP could have a non-DNA binding role in augmenting TFIIIA interaction to the IIIC complex and/or IIIB and/or pol III. Such a role might be analogous to the co-activators of pol II transcription. As a modulator, it could have a role in stimulating a basal rate of 5S gene transcription depending on changing cellular requirements. TFIIIA-intP could also have a role in altering the conformation of TFIIIA from an inactive to an active state. A previous study indicated that the protein we identified as a TFIIIA-intP was found to interact with the adenovirus E3 14.7 kDa protein in a yeast two-hybrid screen and was termed FIP-2 (44). As assayed by fluorescence microscopy, FIP-2 was found in the cell nucleus and the authors suggested that this protein may be a transcription factor because of the numerous leucine zipper-like motifs. Adenovirus is known to enhance RNA polymerase III transcription including 5S RNA synthesis in human cells (45). There may be a mechanistic connection between adenovirus infection and potential FIP-2/TFIIIA-intP stimulation of 5S gene transcription.
###end p 38
###begin title 39
Figures and Tables
###end title 39
###begin p 40
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 112 113 112 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 361 362 361 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 369 370 369 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 399 411 399 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 416 424 416 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X.laevis</italic>
###xml 399 411 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 416 424 <span type="species:ncbi:8355">X.laevis</span>
 TFIIIA amino acid structures used in two-hybrid plasmid constructs. I-IX indicate the order of the nine Cys2His2 zinc fingers from the N- to C-terminal direction. An arrow marks the site where the TFIIIA polypeptide was fused to the C-terminus of the Gal4 DNA binding domain; the entire polypeptide from the arrow to the C-terminus was used in the construct. (A) and (B), amino acid sequences from S.cerevisiae and X.laevis TFIIIA.
###end p 40
###begin p 41
###xml 352 354 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;3</sup>
###xml 397 404 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 583 590 583 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 23 28 <span type="species:ncbi:4932">yeast</span>
###xml 85 90 <span type="species:ncbi:4932">yeast</span>
###xml 370 375 <span type="species:ncbi:4932">yeast</span>
###xml 415 420 <span type="species:ncbi:4932">yeast</span>
 Protein expression in yeast from TFIIIA-Gal4 fusion plasmids. Plasmid construction, yeast transformation, lysate preparation, antibodies, SDS-PAGE and western blotting are described in Materials and Methods. Dashes on the left margin of gel blot mark approximate electrophoretic migration distances for proteins of the indicated molecular weights (x10-3). Lysates from yeast cells expressing the Xenopus TFIIIA or yeast TFIIIA-Gal4 fusions were electrophoresed in lanes 1-4 and 5-8 respectively. The blots were probed with either anti-Gal4 DNA binding domain antibody (1-4) or anti-Xenopus TFIIIA antibody (5-8) and alkaline phosphatase-conjugated secondary antibody.
###end p 41
###begin p 42
###xml 193 194 190 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 198 199 195 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 203 204 200 201 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 211 212 208 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 248 255 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 64 69 <span type="species:ncbi:4932">yeast</span>
###xml 75 80 <span type="species:ncbi:4932">yeast</span>
###xml 264 269 <span type="species:ncbi:4932">yeast</span>
###xml 278 283 <span type="species:ncbi:4932">yeast</span>
###xml 339 344 <span type="species:ncbi:4932">yeast</span>
###xml 396 399 <span type="species:ncbi:10116">rat</span>
 Binding specificity of candidate TFIIIA-interacting protein in yeast. The yeast beta-galactosidase filter assay was performed as described in Materials and Methods. Cells streaked on filters (A), (B), (C) and (D) contained Gal4 DNA binding domain-Xenopus TFIIIA, yeast TFIIIA, yeast SNF1 or lamin fusion plasmids respectively. Individual yeast clones 1, 2, 3 and 4 also contained different pACT rat cDNAs fused to Gal4 activation domains and were obtained from the two-hybrid screens.
###end p 42
###begin p 43
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 48 51 <span type="species:ncbi:10116">rat</span>
###xml 242 247 <span type="species:ncbi:9606">human</span>
###xml 248 251 <span type="species:ncbi:10116">rat</span>
###xml 362 365 <span type="species:ncbi:10116">rat</span>
 Amino acid sequence alignment of the human and rat TFIIIA-intP. DNA sequences were obtained as described in Materials and Methods. Dark and light shaded boxes indicate amino acid sequence identities and similarities respectively between the human rat TFIIIA-intP sequences; dashes indicate amino acid deletions. The shared consensus sequence is given below the rat TFIIIA-intP sequence.
###end p 43
###begin p 44
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 198 209 <span type="species:ncbi:3704">horseradish</span>
 Immunoprecipitation of the TFIIIA-TFIIIA-intP complex. Preparation of recombinant Xenopus TFIIIA and human TFIIIA-intP, binding reaction conditions, immunoprecipitations and western blotting using horseradish peroxidase-conjugated secondary antibody were performed as described in Materials and Methods. Binding reaction components are indicated above lanes 1-3.
###end p 44
###begin p 45
###xml 259 260 259 260 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 288 289 288 289 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 424 425 424 425 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
###xml 71 74 <span type="species:ncbi:10116">Rat</span>
###xml 151 162 <span type="species:ncbi:3704">horseradish</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
 Co-chromatography of TFIIIA and TFIIIA-intP from a rat liver extract. Rat liver cell extracts, chromatographic separations and western blotting using horseradish peroxidase-conjugated secondary antibody were performed as described in Materials and Methods. (A) Chromatography protocol; (B) western blot of phosphocellulose flow-through (lane 1) and recombinant human TFIIIA-intP (lane 2) probed with TFIIIA-intP antibody; (C), western blot of DEAE-5PW column fractions probed with TFIIIA-intP antibody (top) or TFIIIA antibody (bottom).
###end p 45
###begin p 46
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 274 275 274 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 285 286 285 286 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 477 484 469 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 765 772 745 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 936 943 908 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 549 554 <span type="species:ncbi:9606">human</span>
###xml 640 645 <span type="species:ncbi:9606">human</span>
###xml 849 854 <span type="species:ncbi:9606">human</span>
###xml 999 1004 <span type="species:ncbi:9606">human</span>
 Effect of TFIIIA-intP on 5S RNA gene or adenovirus VA gene transcription in vitro. Preparation of recombinant proteins, transcription assays and gel electrophoresis were performed as described in Materials and Methods. Transcription reactions electrophoresed in lanes 1-6 (A) or 2-8 (B) contained 0.5 microg 5S gene or VA gene plasmid respectively. 5S and VA RNA transcripts are demarcated in the right margins. Reactions in lanes 2 and 3 (A) contained 0.2 microg recombinant Xenopus TFIIIA and lane 3 additionally contained 0.1 microg recombinant human TFIIIA-intP. Reactions in lanes 4-6 (A) contained 0.1, 0.2 or 0.4 microg recombinant human TFIIIA-intP. In (B), transcription reactions electrophoresed in lanes 3 and 4 contained 0.2 and 0.3 microg recombinant Xenopus TFIIIA; reactions in lanes 5 and 6 contained 0.1 and 0.2 microg recombinant human TFIIIA-intP; reactions in lanes 7 and 8 contained 0.2 and 0.3 microg recombinant Xenopus TFIIIA respectively and 0.1 and 0.2 microg recombinant human TFIIIA-intP respectively. The reaction electrophoresed in lane 1 contained no VA gene.
###end p 46
###begin title 47
ACKNOWLEDGEMENTS
###end title 47
###begin p 48
The authors thank Michael Conrad, Anna Dominguez, James Hocker, Takumi Kamura, Martha Ogilvie and John Wickham for technical assistance. This work was supported by the Oklahoma Medical Research Foundation (M.D), National Institutes of Health (B.R.), Howard Hughes Medical Institute (J.W.C., Associate Investigator), National Institutes of Health (R.C.C.) and Department of Defense (J.H.).
###end p 48
###begin title 49
REFERENCES
###end title 49

